butyric acid has been researched along with Idiopathic Parkinson Disease in 6 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Research has connected Parkinson's disease (PD) with impaired intestinal barrier." | 1.72 | Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice. ( Ding, ST; Jian, YX; Lei, YH; Liu, HD; Liu, MR; Miao, WT; Xu, JY; Xu, RC; Xu, WX; Yan, N, 2022) |
| "Therapeutic options for Parkinson's disease (PD) are limited to a symptomatic approach, making it a global threat." | 1.62 | Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease. ( Dubey, SK; K C, S; Kakoty, V; Taliyan, R; Yang, CH, 2021) |
| "However, the pathogenesis of Parkinson's disease is still incompletely understood to date." | 1.42 | G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients. ( Alquézar, C; Bartolomé, F; Bermejo-Pareja, F; de la Encarnación, A; Esteras, N; Martín-Requero, Á; Molina, JA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, RC | 1 |
| Miao, WT | 1 |
| Xu, JY | 1 |
| Xu, WX | 1 |
| Liu, MR | 1 |
| Ding, ST | 1 |
| Jian, YX | 1 |
| Lei, YH | 1 |
| Yan, N | 1 |
| Liu, HD | 2 |
| Guo, TT | 1 |
| Zhang, Z | 1 |
| Sun, Y | 1 |
| Zhu, RY | 1 |
| Wang, FX | 1 |
| Ma, LJ | 1 |
| Jiang, L | 1 |
| Kakoty, V | 1 |
| K C, S | 1 |
| Dubey, SK | 1 |
| Yang, CH | 1 |
| Taliyan, R | 1 |
| Paiva, I | 1 |
| Pinho, R | 1 |
| Pavlou, MA | 1 |
| Hennion, M | 1 |
| Wales, P | 1 |
| Schütz, AL | 1 |
| Rajput, A | 1 |
| Szego, ÉM | 1 |
| Kerimoglu, C | 1 |
| Gerhardt, E | 1 |
| Rego, AC | 1 |
| Fischer, A | 1 |
| Bonn, S | 1 |
| Outeiro, TF | 1 |
| Esteras, N | 1 |
| Alquézar, C | 1 |
| Bartolomé, F | 1 |
| de la Encarnación, A | 1 |
| Bermejo-Pareja, F | 1 |
| Molina, JA | 1 |
| Martín-Requero, Á | 1 |
| Jin, H | 1 |
| Kanthasamy, A | 1 |
| Harischandra, DS | 1 |
| Kondru, N | 1 |
| Ghosh, A | 1 |
| Panicker, N | 1 |
| Anantharam, V | 1 |
| Rana, A | 1 |
| Kanthasamy, AG | 1 |
6 other studies available for butyric acid and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Butyric Acid; Claudin-1; Cytokines; Disease M | 2022 |
Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Topics: Animals; Butyric Acid; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Inflammation; | 2023 |
Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Butyric Acid; Disease Models, Animal; Neuroprotective Agents; Parkinson Di | 2021 |
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage.
Topics: alpha-Synuclein; Butyric Acid; Cell Culture Techniques; DNA Damage; Dopaminergic Neurons; Gene Expre | 2017 |
G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients.
Topics: Aged; Aged, 80 and over; Butyric Acid; Case-Control Studies; Cell Cycle Checkpoints; Cell Cycle Prot | 2015 |
Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
Topics: Acetylation; Animals; Brain; Butyric Acid; Cell Death; Cell Line; Dopaminergic Neurons; Epigenesis, | 2014 |